Longevity Treatment Guides

Verify licenses, complete indicated workup before nootropics or devices, and refer progressive decline. Cognitive scores and brain data need a privacy plan, not a marketing funnel.

Cognitive training has limited transfer beyond practiced tasks. Nootropic supplements are not FDA-approved cognition drugs. Sleep, hearing, mood, and vascular risk come first.

Focus and memory complaints have many causes. Screen ADHD, sleep, depression, medicines, hearing, and vascular risk before paying for cognitive optimization.

Sleep and exercise have the strongest lifestyle evidence for cognitive performance. Screen sleep apnea and depression first. Activity supports brain health; it is not a dementia cure.

Nonspecific brain fog is not the same as progressive cognitive decline. Screen medicines, sleep, mood, thyroid, B12, hearing, and vascular risk before buying nootropics.

Most nootropics are not FDA-approved cognition drugs. Prescription stimulants need a clinician. Watch interactions, contamination, and disease-treatment claims on supplement labels.

Start with hearing, sleep, blood pressure, activity, mood, and medicines. Devices and nootropics come last, with limited evidence, and they do not replace a workup.

Brain-training apps and wearables rarely transfer to everyday thinking. They are not a diagnosis. Ask what the claim is, and who stores your cognitive data.

A structured screen of attention, memory, and related skills. It is not a dementia or ADHD diagnosis. Progressive decline needs licensed medical referral, not repeat wellness testing.

Structured practice can improve trained tasks. Transfer to daily function is limited. It is not a dementia treatment and should not delay evaluation of cognitive decline.